CD274 and melanoma: Targeting the UVB-induced HMGB1/RAGE axis could inhibit PD-L1 induction in UVB-exposed melanocytes and melanoma cells, which may serve as potential drug targets to mitigate immune escape of malignant and premalignant melanocytes.